Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
December 7, 2022
Portal Instruments appoints Dr. Veena Rao, PhD, as Chief Business Officer
December 5, 2022
IDEAYA Biosciences Receives Fast Track Designation for Darovasertib Combination Therapy with Crizotinib for the Treatment of Metastatic Uveal Melanoma
December 2, 2022
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
December 1, 2022
Womens Health Advocate Amy Schumer Joins TMRW Life Sciences as Investor
December 1, 2022
Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388
December 1, 2022
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
November 30, 2022
Dianthus Therapeutics Announces First Participant Dosed in Phase 1 Trial of DNTH103, a Selective Inhibitor of the Classical Complement Pathway
November 30, 2022
Lilly and Akouos Announce Expiration of Akouos Tender Offer
November 29, 2022
Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical Genome Mapping (OGM) and Address Difficult Sample Types in New Applications with Isotachophoresis (ITP) on the Ionic Purification System
November 28, 2022
CinCor Pharma Announces Topline Data for Phase 2 HALO Trial Evaluating Selective Aldosterone Synthase Inhibitor Baxdrostat in Uncontrolled Hypertension
« Previous Page
1
2
3
4
…
17
Next Page »